J Korean Bone Joint Tumor Soc.  2011 Jun;17(1):17-22. 10.5292/jkbjts.2011.17.1.17.

Chondrosarcoma Arising from Benign Bone Tumor due to Malignant Transformation

Affiliations
  • 1Department of Orthopedic Surgery, Korea Cancer Center Hospital, Seoul, Korea. dgjeon@kcch.re.kr

Abstract

PURPOSE
We analyzed the oncological outcome and prognostic factor of the chondrosarcoma arising from benign bone tumor due to malignant transformation.
MATERIALS AND METHODS
From April 1986 to April 2009, 18 cases were considered eligible. We analyzed retrospectively the patient's characteristics and prognostic factors that affect to the local recurrence and distant metastasis.
RESULTS
As classified by primary benign bone tumor, 4 cases were solitary osteochondroma, 11 cases were multiple osteochondromatosis and 3 cases were multiple enchondromatosis. The mean follow-up period was 85 months. The 5-year disease free survival rate of 18 patients was 85.9%. Their overall MSTS score was 25.2 (84%). There were local recurrence in 3 cases and no distant metastasis. We found that tumor location and surgical margin affected to the prognosis significantly.
CONCLUSION
In secondary chondrosarcoma patients, the prognosis was good relatively and tumor location and surgical margin are important prognosis factor.

Keyword

chondrosarcoma; maliganant transformation; prognostic factor

MeSH Terms

Chondrosarcoma
Disease-Free Survival
Enchondromatosis
Follow-Up Studies
Humans
Neoplasm Metastasis
Osteochondroma
Osteochondromatosis
Prognosis
Recurrence
Retrospective Studies

Figure

  • Figure 1. Patient was a 30-year old man who was diagnosed as Oiller's disease. (A) Bone scan shows multiple irregular uptakes. (B) This MRI was taken just before incisional biopsy. On the T1W1 MRI image, there are mixed low-high SI on T2WI and heterogeneous enhancement in both hip bones and proximal femurs. (C) Preoperative radiograph shows osteolytic bony destruction of right acetabulum, ischium and superior pubic ramus. (D) This radiograph was eight months after curettage and bone cementation. The patients is alive with disease.


Reference

1. Gelderblom H, Hogendoorn PC, Dijkstra SD, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008; 13:320–9.
Article
2. Ahmed AR, Tan TS, Unni KK, Collins MS, Wenger DE, Sim FH. Secondary chondrosarcoma in osteochondroma: report of 107 patients. Clin Orthop Relat Res. 2003; 411:193–206.
Article
3. Lin PP, Moussallem CD, Deavers MT. Secondary chondrosarcoma. J Am Acad Orthop Surg. 2010; 18:608–15.
Article
4. Altay M, Bayrakci K, Yildiz Y, Erekul S, Saglik Y. Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients. J Orthop Sci. 2007; 12:415–23.
Article
5. Bieling P, Rehan N, Winkler P, et al. Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol. 1996; 14:848–58.
Article
6. Gobel V, Jurgens H, Etspuler G, et al. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol. 1987; 113:187–91.
7. Dahlin DC, Henderson ED. Chondrosarcoma, a surgical and pathological problem; review of 212 cases. J Bone Joint Surg Am. 1956; 38-A:1025–38.
8. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980; 153:106–20.
Article
9. Enneking WF, Dunham W, Gebhardt MC, Malawer M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993; 286:241–6.
Article
10. Murphey MD, Choi JJ, Kransdorf MJ, Flemming DJ, Gannon FH. Imaging of osteochondroma: variants and complications with radiologic-pathologic correlation. Radiographics. 2000; 20:1407–34.
Article
11. Coley BL, Higinbotham NL. Secondary chondrosarcoma. Ann Surg. 1954; 139:547–59.
Article
12. Garrison RC, Unni KK, McLeod RA, Pritchard DJ, Dahlin DC. Chondrosarcoma arising in osteochondroma. Cancer. 1982; 49:1890–7.
Article
13. Merchan EC, Sanchez-Herrera S, Gonzalez JM. Secondary chondrosarcoma. Four cases and review of the literature. Acta Orthop Belg. 1993; 59:76–80.
14. Schaison F, Anract P, Coste F, De Pinieux G, Forest M, Tomeno B. Chondrosarcoma secondary to multiple cartilage diseases. Study of 29 clinical cases and review of the literature. Rev Chir Orthop Reparatrice Appar Mot. 1999; 85:834–45.
15. Wuisman PI, Jutte PC, Ozaki T. Secondary chondrosarcoma in osteochondromas. Medullary extension in 15 of 45 cases. Acta Orthop Scand. 1997; 68:396–400.
Article
16. Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer. 1977; 40:818–31.
17. Flemming DJ, Murphey MD. Enchondroma and chondrosarcoma. Semin Musculoskelet Radiol. 2000; 4:59–71.
Article
18. Marcove RC, Mike V, Hutter RV, et al. Chondrosarcoma of the pelvis and upper end of the femur. An analysis of factors influencing survival time in one hundred and thirteen cases. J Bone Joint Surg Am. 1972; 54:561–72.
19. Lee FY, Mankin HJ, Fondren G, et al. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am. 1999; 81:326–38.
20. Gitelis S, Bertoni F, Picci P, Campanacci M. Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli. J Bone Joint Surg Am. 1981; 63:1248–57.
Article
21. Pierz KA, Womer RB, Dormans JP. Pediatric bone tumors: osteosarcoma ewing's sarcoma, and chondrosarcoma associated with multiple hereditary osteochondromatosis. J Pediatr Orthop. 2001; 21:412–8.
Article
Full Text Links
  • JKBJTS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr